Semaglutide is a weekly weight-loss injection that contains the active ingredient semaglutide, a GLP-1 receptor agonist. Semaglutide works by mimicking the natural GLP-1 hormone, which helps regulate appetite, slow digestion, and increase feelings of fullness after eating. This leads to reduced calorie intake and steady, long-term weight loss.

Semaglutide is taken once a week along with a healthy diet and regular exercise. Clinical studies have shown that semaglutide can help patients lose up to 15% of their initial body weight by week 68 when using the highest FDA-approved dose of 2.4 mg (Wegovy protocol).

To be eligible for Semaglutide for weight loss, you must have a body mass index (BMI) of 30 kg/m² or more (obesity), or a BMI of 27 kg/m² or more (overweight) with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea.

Address

Say Hello